Cargando…
Y-box binding protein YBX1 and its correlated genes as biomarkers for poor outcomes in patients with breast cancer
The enhanced expression of the Y-box binding protein YBX1 is consistently correlated with poor outcomes or reduced survival of breast cancer patients. However, the mechanism underlying the association between increased YBX1 expression and poor outcomes has yet to be revealed. We searched a database...
Autores principales: | Shibata, Tomohiro, Tokunaga, Eriko, Hattori, Satoshi, Watari, Kosuke, Murakami, Yuichi, Yamashita, Nami, Oki, Eiji, Itou, Junji, Toi, Masakazu, Maehara, Yoshihiko, Kuwano, Michihiko, Ono, Mayumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324687/ https://www.ncbi.nlm.nih.gov/pubmed/30647855 http://dx.doi.org/10.18632/oncotarget.26469 |
Ejemplares similares
-
Oncogenic Y‐box binding protein‐1 as an effective therapeutic target in drug‐resistant cancer
por: Kuwano, Michihiko, et al.
Publicado: (2019) -
Molecular mechanisms regulating the hormone sensitivity of breast cancer
por: Tokunaga, Eriko, et al.
Publicado: (2014) -
Expression of APOBEC3B mRNA in Primary Breast Cancer of Japanese Women
por: Tokunaga, Eriko, et al.
Publicado: (2016) -
Phosphorylation of mTOR Ser2481 is a key target limiting the efficacy of rapalogs for treating hepatocellular carcinoma
por: Watari, Kosuke, et al.
Publicado: (2016) -
AXL/CDCP1/SRC axis confers acquired resistance to osimertinib in lung cancer
por: Murakami, Yuichi, et al.
Publicado: (2022)